Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 mai 2013 14h06 HE | Source: Veloxis Pharmaceuticals A/S

European Medicines Agency (EMA) Accepts Veloxis’ Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients

Company Announcement no. 13/2013 To: NASDAQ OMX Copenhagen...
21 mai 2013 14h06 HE | Source: Veloxis Pharmaceuticals A/S

Det Europæiske Lægemiddelagentur starter behandling af Veloxis’ ansøgning om markedsføringstilladelse for LCP-Tacro™ til behandling af nyretransplantationspatienter

Selskabsmeddelelse nr. 13/2013 Til: NASDAQ OMX Copenhagen...
20 mai 2013 02h30 HE | Source: Veloxis Pharmaceuticals A/S

Endelige data fra det kliniske STRATO studie viser LCP-TacroTM’s potentiale til forbedring af tacrolimus-induceret tremor (rysten)

Selskabsmeddelelse nr. 12/2013 Til: NASDAQ OMX Copenhagen...
20 mai 2013 02h30 HE | Source: Veloxis Pharmaceuticals A/S

Final STRATO Clinical Study Data Demonstrates Potential for LCP-TacroTM to Improve Tacrolimus-Induced Tremors

Company Announcement no. 12/2013 To: NASDAQ OMX Copenhagen...
15 mai 2013 11h12 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals offentliggør finansielt resultat for de første 3 måneder af 2013

Selskabsmeddelelse nr. 11/2013 Til: NASDAQ OMX Copenhagen...
15 mai 2013 11h12 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces financial results for the first three months of 2013

Company Announcement no. 11/2013 To: NASDAQ OMX Copenhagen...
07 mai 2013 03h30 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af kvartalsrapporten for 1. kvartal 2013 – resultater fra 1. januar til 31. marts 2013

Investor service meddelelse nr. 2/2013 Til: NASDAQ OMX København ...
07 mai 2013 03h30 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for first Quarter 2013 – results from 1 January to 31 March, 2013

Investor service announcement no. 2/2013 To: NASDAQ OMX Copenhagen ...
01 mai 2013 04h35 HE | Source: Veloxis Pharmaceuticals A/S

Nye vedtægter

Selskabsmeddelelse nr. 10/2013 Til: NASDAQ OMX Copenhagen...
01 mai 2013 04h35 HE | Source: Veloxis Pharmaceuticals A/S

New Articles of Association

Company Announcement no. 10/2013 To: NASDAQ OMX Copenhagen...

Page précédente